These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22997921)

  • 1. [Efficacy of combined immunocorrection in the treatment of chronic viral hepatitis C].
    Frolov VM; Sotskaia IaA
    Ter Arkh; 2012; 84(6):60-5. PubMed ID: 22997921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical efficiency of reamberin - cycloferon combination in treatment of hepatic cirrhosis associated with chronic HCV infection].
    Frolov VM; Sotskaia IaA; Kruglova OV
    Eksp Klin Farmakol; 2012; 75(8):34-8. PubMed ID: 23012994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Estimation of clinical-pathogenetic efficiency of reamberin and cycloferon application in patients with the severe form of acute tonsillitis].
    Frolov VM; Tereshkin VA; Sotskaia IaA; Peresadin NA; Kruglova OV
    Lik Sprava; 2013 Mar; (2):124-9. PubMed ID: 24605622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INFLUENCE OF REAMBERIN® AND CYCLOFERON® ON CONCETRATION OF "AVERAGE MOLECULES" IN SERUM OF PATIENTS WITH RECCURENT DEPRESSIVE DISORDERS IN OUTPATIENT OBSERVATION].
    Tereshina IF; Kut'ko II; Rachkauskas GS
    Lik Sprava; 2014; (7-8):93-8. PubMed ID: 26118092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of the combination of cycloferon and reamberin in treatment of resistant patients with paranoid schizophrenia].
    Maruta NA; Rachkauskas GS; Frolov VM; Tereshina IF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(12):36-9. PubMed ID: 22433807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectivity of detoxification preparation reamberin in complex treatment of the patients with chronic cholecystitis combined with chronic pancreatitis on background of HCV-infection].
    Sotskaia IaA; Frolov VM; Kruglova OV; Sanzharevskaia IV
    Lik Sprava; 2011; (7-8):64-9. PubMed ID: 22768740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of immune response to etiotropic and pathogenetic therapy in children with chronic hepatitis C].
    Vasil'eva DK; Goriacheva LG; Monakhova NE
    Eksp Klin Farmakol; 2011; 74(12):33-5. PubMed ID: 22379880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interferon status in the treatment of neuroleptic-resistant patients with paranoid schizophrenia].
    Maruta NA; Rachkauskas GS; Frolov VM; Vysochin EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(3 Pt 1):31-3. PubMed ID: 22677752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Increase of antibacterial therapy efficacy in chronic sepsis with cycloferon and reamberin combination].
    Frolov VM; Peresadin NA; Chkhetiani RB; Kruglova OV
    Antibiot Khimioter; 2012; 57(5-6):18-27. PubMed ID: 23156040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunological and mutagenic actions of ribavirin monotherapy preceding combination therapy with interferon for patients with chronic hepatitis C.
    Ogawa K; Hige S; Nakanishi M; Yamamoto Y; Chuma M; Nagasaka A; Asaka M
    Antivir Ther; 2009; 14(4):513-22. PubMed ID: 19578236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Helper T cell cytokine response to ribavirin priming before combined treatment with interferon alpha and ribavirin for patients with chronic hepatitis C.
    Furusyo N; Kubo N; Toyoda K; Takeoka H; Nabeshima S; Murata M; Nakamuta M; Hayashi J
    Antiviral Res; 2005 Jul; 67(1):46-54. PubMed ID: 15913800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus free-virion and immune-complex dynamics during interferon therapy with and without ribavirin in genotype-1b chronic hepatitis C patients.
    Fujita N; Kaito M; Tanaka H; Horiike S; Urawa N; Sugimoto R; Konishi M; Watanabe S; Adachi Y
    J Viral Hepat; 2006 Mar; 13(3):190-8. PubMed ID: 16475995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group.
    Glue P; Rouzier-Panis R; Raffanel C; Sabo R; Gupta SK; Salfi M; Jacobs S; Clement RP
    Hepatology; 2000 Sep; 32(3):647-53. PubMed ID: 10960463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)].
    Sologub TV; Romantsev MG; Shul'diakov AA; Lin'kova IuN; Radchenko VG; Kovalenko AL
    Ter Arkh; 2010; 82(10):78-81. PubMed ID: 21341470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunomodulators in the "gold standard" of the chronic viral hepatitis C therapy].
    Romantsov MG; Kovalenko SN; Sologub TV; Anikina OV
    Antibiot Khimioter; 2008; 53(3-4):18-22. PubMed ID: 18942421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of treatment outcome in chronic hepatitis C patients based on early viral dynamics during high-dose induction interferon and ribavirin therapy.
    Kim TH; Kim KA; Lim YS; Gwak GY; Yoon JH; Kang GH; Lee HS
    Intervirology; 2005; 48(4):230-8. PubMed ID: 15920347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cycloferon administration in chronic pyelonephritis: changes in interferon status].
    Kudriashova IP; Ospel'nikova TP; Ershov FI
    Ter Arkh; 2011; 83(6):33-5. PubMed ID: 21786573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of pegylated interferon alpha and ribavirin therapy of chronic hepatitis C on peripheral blood and intrahepatic lymphocytes].
    Tomasiewicz K; Modrzewska R; Korobowicz E
    Pol Merkur Lekarski; 2009 Jan; 26(151):19-23. PubMed ID: 19391501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Minimization of endogenous intoxication syndrome by individual choice of drugs for therapy of chronic hepatitis].
    Vasil'eva DK; Goriacheva LG; Kotiv MIa; Alekseeva LA; Romantsov MG; Bessonova TV
    Antibiot Khimioter; 2011; 56(3-4):46-50. PubMed ID: 21913409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.
    Asahina Y; Izumi N; Uchihara M; Noguchi O; Tsuchiya K; Hamano K; Kanazawa N; Itakura J; Miyake S; Sakai T
    Hepatology; 2001 Aug; 34(2):377-84. PubMed ID: 11481623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.